FDA
-
-
-
-
-
-
-
Avalon GloboCare rebrands as Change Agents Corp., shifts to AI
-
-
-
-
-
-
-
Verrica Pharma signs Israel deal for skin disease treatment YCANTH
-
-
-
-
-
-
-
Agios drops tebapivat in sickle cell after Phase 2 falls short
-
-
-
-
-
-
-
Telix doses first patient in Phase 3 kidney cancer drug trial
-
-
-
-
-
-
-
BillionToOne names oncology veteran as chief medical officer
-
-
-
-
-
-
-
Scholar Rock says apitegromab EU approval delayed by facility review
-
-
-
-
-
-
-
USANA renews four-year nutrition deal with Nordiq Canada
-
326,104 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

